|
|
Volumn 165, Issue 3, 2013, Pages 575-577
|
|
Statins and atrial fibrillation in patients with left ventricular dysfunction: Insights from the AF-CHF trial
a
a
a
a
a
a
a
a
a
a
a
a
|
|
Author keywords
Atrial fibrillation; Heart failure; Hospitalization; Mortality; Statins
|
|
Indexed keywords
ANTICOAGULANT AGENT;
CALCIUM ANTAGONIST;
CREATININE;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
SPIRONOLACTONE;
AGED;
CARDIOVASCULAR MORTALITY;
CONGESTIVE HEART FAILURE;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DISEASE ASSOCIATION;
DISEASE DURATION;
DRUG EFFICACY;
FEMALE;
HEART ATRIUM FIBRILLATION;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE FAILURE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
OXIDATIVE STRESS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
CARDIOVASCULAR RESPONSE;
CARDIOVERSION;
CLINICAL ASSESSMENT;
DRUG MEGADOSE;
DRUG RESPONSE;
EVENT FREE SURVIVAL;
HEART FAILURE;
META ANALYSIS (TOPIC);
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RECURRENT DISEASE;
RISK REDUCTION;
SINUS RHYTHM;
|
|
EID: 84877027189
PISSN: 01675273
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2012.09.033 Document Type: Article |
|
Times cited : (5)
|
|
References (8)
|
